Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert H Belmaker

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Bipolar Disorders|November 7, 2023
Letter to editor: Bipolar disordersRobert H Belmaker
Bipolar Disorders|October 21, 2009
Patient history must be incorporated into any guidelinesRobert H Belmaker
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|October 27, 2010
A yes or no answerRobert H Belmaker
Bipolar Disorders|February 13, 2010
The future of anticonvulsants in bipolar disorderRobert H Belmaker
Pharmaceuticals (Basel, Switzerland)|December 31, 2025
At 75 Years, Is Lithium the Gold Standard in Bipolar Disorder?Robert H Belmaker
The American Journal of Psychiatry|March 4, 2006
Osteoporosis and schizophreniaJoseph Levine, Robert H Belmaker
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|October 31, 2006
Clinical trials of PUFAs in depression: State of the artYamima Osher, Robert H Belmaker, Boris Nemets
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 28, 2002
Lack of effect of acute, subchronic, or chronic stress on glycogen synthase kinase-3beta protein levels in rat frontal cortexNitsan Kozlovsky, Robert H Belmaker, Galila Agam
Psychopharmacology Bulletin|October 17, 2003
New approaches to modeling bipolar disorderHaim Einat, Robert H Belmaker, Husseini K Manji
The International Journal of Neuropsychopharmacology|August 2, 2003
Lack of effect of mood stabilizers or neuroleptics on GSK-3 protein levels and GSK-3 activityNitsan Kozlovsky, Carmit Nadri, Robert H Belmaker, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Bipolar Disorders|November 7, 2023
Letter to editor: Bipolar disordersRobert H Belmaker
Bipolar Disorders|October 21, 2009
Patient history must be incorporated into any guidelinesRobert H Belmaker
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|October 27, 2010
A yes or no answerRobert H Belmaker
Bipolar Disorders|February 13, 2010
The future of anticonvulsants in bipolar disorderRobert H Belmaker
Pharmaceuticals (Basel, Switzerland)|December 31, 2025
At 75 Years, Is Lithium the Gold Standard in Bipolar Disorder?Robert H Belmaker
The American Journal of Psychiatry|March 4, 2006
Osteoporosis and schizophreniaJoseph Levine, Robert H Belmaker
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|October 31, 2006
Clinical trials of PUFAs in depression: State of the artYamima Osher, Robert H Belmaker, Boris Nemets
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 28, 2002
Lack of effect of acute, subchronic, or chronic stress on glycogen synthase kinase-3beta protein levels in rat frontal cortexNitsan Kozlovsky, Robert H Belmaker, Galila Agam
Psychopharmacology Bulletin|October 17, 2003
New approaches to modeling bipolar disorderHaim Einat, Robert H Belmaker, Husseini K Manji
The International Journal of Neuropsychopharmacology|August 2, 2003
Lack of effect of mood stabilizers or neuroleptics on GSK-3 protein levels and GSK-3 activityNitsan Kozlovsky, Carmit Nadri, Robert H Belmaker, et al.
Pageof 5